How far is real life from COPD therapy guidelines? An Italian observational study

Respiratory Medicine

Volumn 106, Issue 7, 2012, Pages 989-997

  Corrado, Antonio ^a   Rossi, Andrea ^b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Appropriateness; Chronic obstructive pulmonary disease; International GOLD guidelines; Pharmacological treatment

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; MUSCARINIC RECEPTOR BLOCKING AGENT; XANTHINE;

AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COMPARATIVE STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG INDICATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR ANTAGONISTS; AGED; ANALYSIS OF VARIANCE; BRONCHODILATOR AGENTS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FORCED EXPIRATORY VOLUME; GUIDELINE ADHERENCE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84861186450     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.03.008     Document Type: Article

References (20)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2008 www.goldcopd.com
2. M. Pearson Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care Thorax 49 Suppl. 1 2004 1 232 (Pubitemid 38339892)
3. National Clinical Guideline Centre Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care 2010 London www.nice.org.uk
4. T.J. Wilt, D. Niewoehner, R. MacDonald, and R.L. Kane Management of stable chronic obstructive pulmonary disease: a systemic review for a clinical practice guideline Ann Intern Med 147 2007 639 653 (Pubitemid 351664485)
5. W. Vincken, J.A. van Noord, A.P. Greefhorst, T.A. Bantje, S. Kesten, L. Korducki, and P.J. Cornelissen Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium Eur Respir J 19 2 2002 209 216 (Pubitemid 34162819)
6. D.A. Mahler, J.F. Donohue, R.A. Barbee, M.D. Goldman, N.J. Gross, M.E. Wisniewski, S.W. Yancey, B.A. Zakes, K.A. Rickard, and W.H. Anderson Efficacy of salmeterol xinafoate in the treatment of COPD Chest 115 4 1999 957 965 (Pubitemid 29193661)
7. R. Dahl, L.A. Greefhorst, D. Nowak, V. Nonikov, A.M. Byrne, M.H. Thomson, D. Till, and G. Della Cioppa Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 5 2001 778 784 (Pubitemid 32881913)
8. N. Roche, T. Lepage, J. Bourcereau, and P. Terrioux Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Eur Respir J 18 6 2001 903 990
9. J. Seaman, A.C. Leonard, and R.J. Panos Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD Int J COPD 5 2010 89 97
10. S. Rennard, M. Decramer, and P.M.A. Calverley Impact of COPD in North America and Europe in 2000: subjects' perspective of confronting COPD international survey Eur Respir J 20 2002 799 805 (Pubitemid 35175112)
11. C.M. Roberts, I. Ryland, D. Lowe, C.E. Bucknall, and M.G. Pearson Audit of acute admissions of COPD: standards of care and management in the hospital setting Eur Respir J 17 2001 343 349 (Pubitemid 32600599)
12. M. Cazzola, G. Bettoncelli, E. Sessa, and C. Cricelli Primary care of the patients with chronic obstructive pulmonary disease in Italy Resp Med 103 4 2009 582 588
13. M. Cazzola, A. Segreti, G. Bettoncelli, L. Calzetta, C. Cricelli, F. Pasqua, and P. Rogliani Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008 Prim Care Respir J 2011; Apr 20 pii: pcrj-2010-11-0136, doi: 10.4104/pcrj.2011.00033. [Epub ahead of print]
14. D.S. Postma, P.M.A. Calverley, S. Suissa, and P.J. Barnes Pro/Con editorials inhaled corticosteroids in COPD: a case in favour/the case against Eur Respir J 34 2009 p. 10-16.19
15. S.E. Marsh, J. Travers, M. Weatherall, M.V. Williams, S. Aldington, P.M. Shirtcliffe, A.L. Hansell, M.R. Nowitz, A.A. McNaughton, J.B. Soriano, and R.W. Beasley Proportional classifications of COPD phenotypes Thorax 63 9 2008 761 767
16. L.M. Fabbri, M. Romagnoli, and L. Corbetta Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease Am J Respir Crit Care Med 167 2003 418 424 (Pubitemid 36216426)
17. S.R. Kim, and Y.K. Rhee Overlap between asthma and COPD: where the two diseases converge Allergy Asthma Immunol Res 2 4 2010 October 209 214
18. J.R. Hurst, J. Vestbo, A. Anzueto, N. Locantore, H. Mullerova, R. Tal-Singer, B. Miller, D.A. Lomas, A. Agusti, W. MacNee, P. Calverly, S. Rennard, E.F.M. Wouters, and J.A. Wedzicha Susceptibility to exacerbation in chronic obstructive pulmonary disease New Engl J Med 363 2010 1128 1138
19. C.R. Jenkins, P.W. Jones, P.M.A. Calverly, B. Celli, J.A. Anderson, G.T. Ferguson, J.C. Yates, L.R. Willits, and J. Vesbo Efficacy of salmeterol/fluticasone proprionate by GOLD stage of chronic obstructive pulmonary disease:analysis from the randomised, placebo-controlled TORCH study Respir Res 10 2009 59
20. J.E. Heffner, and R. Ellis The guideline approach to chronic obstructive pulmonary disease: how effective? Respir Care 48 12 2003 1257 1266